Komori
Fuso Pharmaceutical Industries (4538) · RiskFirst statedLatest Earnings (2026-08-10): "Restated"

Risk of Raw Material Procurement and Supply Chain Disruptions

First written in FY2026. 1 of 2 entries say "Restated". Latest entry: 2026-08-10.

2entries
1years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2026 – 2026-08-102026: 22026
Same theme, other companies

The whole theme swung hardest in 2020: 67 of 114 companies on the "Worse" side.

101 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 199 companies compared. The sentences above are computed from all 199.Comparing 200 of the theme's 410 threads.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Fuso Pharmaceutical Industries yet. It last moved in the Earnings of 2026-08-10: "Restated".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Risk of Raw Material Procurement and Supply Chain Disruptions | Fuso Pharmaceutical Industries,Ltd. (4538) | Komori